Progress in Cancer Immunotherapy

Released on by Shuren Zhang
preview-18

  • Progress in Cancer Immunotherapy Book Detail

  • Author : Shuren Zhang
  • Release Date : 2016-05-30
  • Publisher : Springer
  • Genre : Medical
  • Pages : 293
  • ISBN 13 : 9401775559
  • File Size : 9,9 MB
DOWNLOAD BOOK

Progress in Cancer Immunotherapy by Shuren Zhang PDF Summary

Book Description: This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.

Disclaimer: www.yourbookbest.com does not own Progress in Cancer Immunotherapy books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Progress in Cancer Immunotherapy

Progress in Cancer Immunotherapy

File Size : 50,50 MB
Total View : 1830 Views
DOWNLOAD

This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecula

Immunotherapy of Cancer

Immunotherapy of Cancer

File Size : 82,82 MB
Total View : 6865 Views
DOWNLOAD

This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy